These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28721629)

  • 1. EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.
    La Rocca F; Airoldi I; Di Carlo E; Marotta P; Falco G; Simeon V; Laurenzana I; Trino S; De Luca L; Todoerti K; Villani O; Lackmann M; D'Auria F; Frassoni F; Neri A; Del Vecchio L; Musto P; Cilloni D; Caivano A
    Cell Oncol (Dordr); 2017 Oct; 40(5):483-496. PubMed ID: 28721629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epha3 acts as proangiogenic factor in multiple myeloma.
    Caivano A; La Rocca F; Laurenzana I; Annese T; Tamma R; Famigliari U; Simeon V; Trino S; De Luca L; Villani O; Berardi S; Basile A; Vacca A; Saglio G; Del Vecchio L; Musto P; Cilloni D
    Oncotarget; 2017 May; 8(21):34298-34309. PubMed ID: 28415715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
    Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
    Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EphA3 receptor is expressed in a subset of rhabdomyosarcoma cell lines and suppresses cell adhesion and migration.
    Clifford N; Smith LM; Powell J; Gattenlöhner S; Marx A; O'Connor R
    J Cell Biochem; 2008 Dec; 105(5):1250-9. PubMed ID: 18814179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
    Wang YD; Hu Y; Zhang L; Huang J; Sun CY
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):659-63. PubMed ID: 18399169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.
    Charmsaz S; Al-Ejeh F; Yeadon TM; Miller KJ; Smith FM; Stringer BW; Moore AS; Lee FT; Cooper LT; Stylianou C; Yarranton GT; Woronicz J; Scott AM; Lackmann M; Boyd AW
    Leukemia; 2017 Aug; 31(8):1779-1787. PubMed ID: 27922598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment.
    Vail ME; Murone C; Tan A; Hii L; Abebe D; Janes PW; Lee FT; Baer M; Palath V; Bebbington C; Yarranton G; Llerena C; Garic S; Abramson D; Cartwright G; Scott AM; Lackmann M
    Cancer Res; 2014 Aug; 74(16):4470-81. PubMed ID: 25125683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.
    Raimondi L; Amodio N; Di Martino MT; Altomare E; Leotta M; Caracciolo D; Gullà A; Neri A; Taverna S; D'Aquila P; Alessandro R; Giordano A; Tagliaferri P; Tassone P
    Oncotarget; 2014 May; 5(10):3039-54. PubMed ID: 24839982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells.
    Lv XY; Wang J; Huang F; Wang P; Zhou JG; Wei B; Li SH
    Oncol Rep; 2018 Oct; 40(4):2408-2416. PubMed ID: 30066881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
    Basile A; Moschetta M; Ditonno P; Ria R; Marech I; De Luisi A; Berardi S; Frassanito MA; Angelucci E; Derudas D; Specchia G; Curci P; Pavone V; Rossini B; Ribatti D; Bottazzi B; Mantovani A; Presta M; Dammacco F; Vacca A
    J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growth.
    To C; Farnsworth RH; Vail ME; Chheang C; Gargett CE; Murone C; Llerena C; Major AT; Scott AM; Janes PW; Lackmann M
    PLoS One; 2014; 9(11):e112106. PubMed ID: 25420155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphA3 is induced by CD28 and IGF-1 and regulates cell adhesion.
    Smith LM; Walsh PT; Rüdiger T; Cotter TG; Mc Carthy TV; Marx A; O'Connor R
    Exp Cell Res; 2004 Jan; 292(2):295-303. PubMed ID: 14697337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth.
    Dhyani A; Machado-Neto JA; Favaro P; Saad ST
    Eur J Cancer; 2015 Jan; 51(2):252-9. PubMed ID: 25483783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.
    Martin SK; Diamond P; Williams SA; To LB; Peet DJ; Fujii N; Gronthos S; Harris AL; Zannettino AC
    Haematologica; 2010 May; 95(5):776-84. PubMed ID: 20015878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.
    Yang Y; Li F; Saha MN; Abdi J; Qiu L; Chang H
    Clin Cancer Res; 2015 May; 21(10):2399-411. PubMed ID: 25724519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma.
    Li S; Fu J; Lu C; Mapara MY; Raza S; Hengst U; Lentzsch S
    Mol Cancer Ther; 2016 Apr; 15(4):711-9. PubMed ID: 26939700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K/Akt inhibitor LY294002 potentiates homoharringtonine antimyeloma activity in myeloma cells adhered to stromal cells and in SCID mouse xenograft.
    Chen P; Wen X; Wang B; Hou D; Zou H; Yuan Q; Yang H; Xie J; Huang H
    Ann Hematol; 2018 May; 97(5):865-875. PubMed ID: 29450644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of interleukin 16 in multiple myeloma.
    Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
    J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucoidan inhibits angiogenesis induced by multiple myeloma cells.
    Liu F; Luo G; Xiao Q; Chen L; Luo X; Lv J; Chen L
    Oncol Rep; 2016 Oct; 36(4):1963-72. PubMed ID: 27498597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.